Arcutis Biotherapeutics Announces $200M At-The-Market Common Stock Offering
ARCUTIS BIOTHERAPEUTICS, INC.$200,000,000Common StockWe have entered into an amended and restated sales agreement, or the Sales Agreement, with TD Cowen, relating to shares of our common stock offered by this prospectus
Arcutis is selling new shares to raise $200 million for the company. When a company does this, watch if the stock gets diluted or if they use the cash wisely.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.